Will symptomatic intracerebral hemorrhages decrease among eligible dabigatran-treated patients who receive intravenous tissue plasminogen activator for acute ischemic stroke?

Lung Chan

doi:10.1001/archneurol.2010.205

Will symptomatic intracerebral hemorrhages decrease among eligible dabigatran-treated patients who receive intravenous tissue plasminogen activator for acute ischemic stroke?

Lung Chan

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1156
Number of pages	1
Journal	Archives of Neurology
Volume	67
Issue number	9
DOIs	https://doi.org/10.1001/archneurol.2010.205
Publication status	Published - Jan 1 2010
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Arts and Humanities (miscellaneous)
Clinical Neurology

Access to Document

10.1001/archneurol.2010.205

Cite this

@article{2db5428230be4b0db0ef99fdf9c0bdb2,

title = "Will symptomatic intracerebral hemorrhages decrease among eligible dabigatran-treated patients who receive intravenous tissue plasminogen activator for acute ischemic stroke?",

author = "Lung Chan",

year = "2010",

month = jan,

day = "1",

doi = "10.1001/archneurol.2010.205",

language = "English",

volume = "67",

pages = "1156",

journal = "Archives of Neurology",

issn = "0003-9942",